Amrutanjan Health Care Ltd
company logo

Amrutanjan Health Care Ltd

AMRUTANJAN Share Price

BSE:590006

NSE:AMRUTANJAN

547.3

7.45 (1.38%)

As on April 17, 2026 at 04:14 PM
Loading chart...

Performance

Loading performance...

539.85

537.70

18372

1.01

1

Fundamentals

1,579.97Cr

27.33

4.62

0.01

20

0.84%

118.32

About

Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Chennai to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore. Pheromones have found wide application as pesticides and are used on cotton crops. The Company is engaged into manufacture, supply, sale of products in pain management, congestion management, beverages & hygiene and services in pain management. Amrutanjan has an agreement with a company in Philadelphia, US, to supply custom-made chemicals for exotic applications like the genetic manipulation of biological matter. It has introduced some new range of products like Pep Pill, Amrutanjan gripe water sans alcohol, Amrutanjan Maha Strong, etc. Plans are afoot to introduce analgesic and antipyretic tablets. The company also plans to launch sanitary napkins soon. The company has approached the US FDA for approval and clearance to sell its new drugs in US. During 1996-97, it has introduced a new product called 'Cold Snap Gel' and also a mint called 'tingle'. Company having two subsidiary companies viz. Amrutanjan Drugs & Chemicals Ltd having holding stake 99.80% & Amrutanjan Finance Ltd, having holding stake is 57.26%. Company has taken efforts to increase the export of fine chemicals & also taking major efforts to give full thrust to existing products. Amrutanjan also modernising its OTC business and expanding its export of fine chemicals which reflects to turnover & net Profit of the Company. 'Diakyur' for the treatment of Diabetes was introduced during 2000-2001. The name of Company changed from 'Amrutanjan Limited' to 'Amrutanjan Health Care Limited' during the year 2007-08. During the year 2009-10, the name of the Fine Chemicals Division of the Company was changed to Pharmaessense Chemistry Services Division. During April 2011 a new division under the name Amrutanjan Pain Management Center also known as CARE Specialized Pain Management Center was launched in Chennai. The Pharmaessense Chemistry Services Division was transferred to a wholly owned Subsidiary Company viz., Amrutanjan Pharmaessense Private Limited with all its assets and liabilities, excluding land during May 2011. Siva's Soft Drink Private Limited was acquired during February 2011 by way of transfer of shares. The Company launched Amrutanjan Headache Faster Relaxation Roll-on 10ml SKU; launched Amrutanjan Faster Relaxation Balm(white) during the year 2014-15. In FY 2016-17, the Subsidiary Company, Amrutanjan Pharmaessense Private Limited (Transferor Company) got merged with the Holding Company (M/s. Amrutanjan Health Care Limited/ Transferee Company), through Scheme of Amalgamation, effective from 1st July 2016. Accordingly, the assets and liabilities of Amrutanjan Pharmaessense Pvt Ltd as at 01st July, 2016 was taken over by the Company. Amrutanjan Comfy Snug Fit Sanitary napkin was launched in 2016-17. Comfy Snug Fit was launched in 2016. The New Maha Strong Pain Balm was re-launched in 2016. Orange variant was launched in addition to existing Apple variant during financial year 2018-19. The flavour Alphonso, the King of Mangoes', was launched in 200 ml Ready- to- drink recyclable PET format. Two more new variants, Comfy XLand Comfy Ultra were launched during 2019-20. The Company re-launched its headache Pain balm in 2021-22. It introduced Amrutanjan Comfy Sung Fit Regular Cottony in FY22. A new product, 'Amrutanjan Stop Pain Dental Gel' was launched for Oral Health Care in 2023. In FY 2024, it launched Pain cream and Electro Plus Lemon and Low-sugar variants. In FY 2025, Company launched Amrutanjan Faster Relaxation Roll-on (AFRR) 2.5ml for pain relief. To address hydration and wellness, Electro+ expanded with two scientifically backed solutions: Electro+ Tetra and Electro+ Powder, both formulated with the WHO-recommended formula to address dehydration from conditions such as diarrhoea and vomiting. To increase affordability and reach, Company launched Electro+ Rehydrate 160ml. Recognising the widespread reliance on oral medication for menstrual pain - often with side effects, Amrutanjan launched the Comfy Period Pain Relief Roll-On: Ayurvedic, side-effect-free, topical solution. A key milestone was the rapid expansion of the Quick Commerce (QCOM) channel, enabling delivery within minutes and reinforcing the brand's promise of relief in 10 minutes.

1936

AMRUTANJAN

NameDesignation
S SambhuprasadChairman / Executive Director / M D / Promoter
Ramaa Prabhakar ArikirevulaNon-Exec & Non-Independent Dir
G RaghavanNon-Exec & Non-Independent Dir
V RajaIndependent Non Exe. Director
Muralidharan SwayambunathanIndependent Non Exe. Director
Meena Lochani RaghunathanIndependent Non Exe. Director
V NagarajIndependent Non Exe. Director
GAGAN PREET SINGHCS / Compliance Officer / General Manager - Legal

Amrutanjan Health Care Ltd FAQs

How do I Buy Amrutanjan Health Care Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Amrutanjan Health Care Ltd shares in BlinkX.

What is the Share Price of Amrutanjan Health Care Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Amrutanjan Health Care Ltd's share price is ₹547.3 as of 2026-04-19.

What is the PE ratio of Amrutanjan Health Care Ltd?

close

Amrutanjan Health Care Ltd's P/E ratio is 27.33 times as of 2026-04-19.

What is the PB ratio of Amrutanjan Health Care Ltd?

close

Amrutanjan Health Care Ltd's most recent financial reports indicate a price-to-book ratio of 4.62, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Amrutanjan Health Care Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Amrutanjan Health Care Ltd's market capitalization is ₹1579.97 Cr as on 2026-04-19.

What is the ROE of Amrutanjan Health Care Ltd?

close

The current financial records of Amrutanjan Health Care Ltd show a 16.53% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Amrutanjan Health Care Ltd?

close

According to Amrutanjan Health Care Ltd's most recent financial filings, the company has a total asset value of ₹296.93, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Amrutanjan Health Care Ltd?

close

The 52-week high/low price of a Amrutanjan Health Care Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Amrutanjan Health Care Ltd's 52-week high and low as of 2026-04-19 are ₹790.95 and ₹486, respectively.